NDC 62484-0020

PURIXAN

Purixan

PURIXAN is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Nova Laboratories, Ltd. The primary component is Mercaptopurine.

• Product ID: 62484-0020_2c83f200-a567-4602-89e0-1ad18ecd42cf
• NDC: 62484-0020
• Product Type: Human Prescription Drug
• Proprietary Name: PURIXAN
• Generic Name: Purixan
• Dosage Form: Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2014-04-28
• Marketing Category: NDA / NDA
• Application Number: NDA205919
• Labeler Name: Nova Laboratories, Ltd
• Substance Name: MERCAPTOPURINE
• Active Ingredient Strength: 20 mg/mL
• Pharm Classes: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 62484-0020-2

1 BOTTLE in 1 CARTON (62484-0020-2) > 100 mL in 1 BOTTLE (62484-0020-1)

• Marketing Start Date: 2014-04-28
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 62484-0020-1 [62484002001]

PURIXAN SUSPENSION

• Marketing Category: NDA
• Application Number: NDA205919
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2014-04-28

NDC 62484-0020-2 [62484002002]

PURIXAN SUSPENSION

• Marketing Category: NDA
• Application Number: NDA205919
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2014-04-28

Drug Details

Pharmacological Class

• Nucleic Acid Synthesis Inhibitors [MoA]
• Nucleoside Metabolic Inhibitor [EPC]